Tax on Patent Royalty Income: How Intellectual Property Is Assessed in Hong Kong

The 2025-2026 fiscal year marks a critical juncture for Hong Kong-based intellectual property (IP) owners. The Inland Revenue Department (IRD) has intensified its scrutiny of royalty income streams, particularly those routed through related parties in low-tax jurisdictions. This shift follows the implementation of the global minimum tax (Pillar Two) and Hong Kong’s own enhanced transfer pricing rules under the Inland Revenue (Amendment) (Taxation of Intellectual Property) Ordinance 2024. For the mid-career professional earning patent royalties from a mainland Chinese licensee, or the small business owner licensing a proprietary software algorithm to a US partner, the question is no longer if the IRD will assess the income, but how. Mischaracterising a royalty stream as a capital receipt, or failing to substantiate the economic ownership of the IP, can trigger a back-tax assessment covering up to six years, plus potential penalties under section 82A of the Inland Revenue Ordinance (Cap. 112). This article provides a practical, source-based guide to how patent royalty income is assessed for Hong Kong profits tax, distinguishing between the territorial source principle, the new economic ownership test, and the specific treatment of qualifying intellectual property under the amended regime.

The Territorial Source Principle and Royalty Income

Hong Kong’s tax system is fundamentally territorial. Under section 14(1) of the Inland Revenue Ordinance (Cap. 112), profits tax is chargeable only on profits “arising in or derived from” Hong Kong. For royalty income, the source is determined by the location where the contract granting the right to use the IP is negotiated, executed, and enforced, and where the payer carries on business. The landmark case of CIR v. Hang Seng Bank Ltd (1991) 3 HKTC 351 established the “operations test,” which the IRD applies to royalty streams.

The Operations Test Applied to Licensing Agreements

The IRD’s Departmental Interpretation and Practice Notes (DIPN) No. 39 (Revised 2023) on Profits Tax and Source of Income provides the authoritative framework. For a royalty to be considered not sourced in Hong Kong, the taxpayer must demonstrate that the essential operations that generated the income—namely, the grant of the licence and the provision of the IP—occurred outside Hong Kong. A Hong Kong company that owns a patent registered in the United States but licenses it to a mainland Chinese manufacturer will face assessment in Hong Kong if the licence agreement is signed in Hong Kong, the royalty payment is received into a Hong Kong bank account, and the company’s management and control of the IP (e.g., deciding on sub-licensing terms, enforcing the patent) is exercised from Hong Kong.

The 2024 Amendment: Economic Ownership vs. Legal Ownership

The Inland Revenue (Amendment) (Taxation of Intellectual Property) Ordinance 2024 introduced a critical change. Effective from 1 April 2024, the IRD now applies an “economic ownership” test for royalty income derived from connected persons. This directly targets structures where a Hong Kong entity legally holds a patent but the underlying research and development (R&D) activities—and thus the economic substance—are performed by a related entity in a jurisdiction with a preferential tax regime. Under the new section 15FA of the IRO, the royalty income is deemed to be sourced in Hong Kong to the extent that the Hong Kong entity fails to demonstrate that it bears the significant people functions (SPFs) related to the IP. The SPFs include decisions on R&D strategy, the management of the IP portfolio, and the assumption of financial risk associated with the IP. A Hong Kong shell company holding a patent without any local R&D staff or strategic decision-making authority will now find its royalty income fully assessable.

Assessment of Patent Royalty Income: Profits Tax or Property Tax?

A common point of confusion is whether patent royalty income falls under profits tax (section 14) or property tax (section 5). The distinction is material: property tax is charged at a flat rate of 15% on the net assessable value, while profits tax for corporations is 16.5% (8.25% on the first HKD 2 million). The IRD’s position, clarified in DIPN No. 44 (Revised 2022) on Property Tax, is that royalties from patents, trademarks, and copyrights are not derived from land or buildings. They are therefore assessable under profits tax as business receipts, provided the taxpayer is carrying on a trade, profession, or business in Hong Kong.

Carrying on a Trade in Hong Kong: The “Trade” Test for IP Owners

For the individual inventor who holds a single patent and licenses it to one company, the IRD may argue that the activity does not constitute a “trade.” In CIR v. L. F. K. (1972) HKLR 375, the court held that isolated transactions of a capital nature are not subject to profits tax. The IRD’s internal guidelines state that a taxpayer who does not engage in systematic R&D, marketing, or ongoing management of the IP is likely to be treated as realising a capital asset. The proceeds would then be a capital receipt, not subject to profits tax. However, for a professional who systematically develops and licenses multiple patents as part of their business activity—a common scenario for a mid-career engineer or a small biotech firm—the IRD will treat the income as trading receipts. The taxpayer should maintain a log of R&D hours, licensing negotiations, and IP management activities to substantiate the trade.

Deductibility of R&D Expenditure and Patent Registration Costs

Where the royalty income is assessable, the taxpayer may deduct expenses wholly and exclusively incurred in the production of that income (section 16(1) of the IRO). This includes:

• R&D costs: Salaries of in-house R&D staff, costs of laboratory equipment, and fees paid to contract research organisations. The IRD accepts these as revenue deductions if they are directly linked to the patent generating the royalty.
• Patent registration and renewal fees: Both in Hong Kong (under the Patents Ordinance, Cap. 514) and overseas. These are deductible in the year of payment.
• Legal and professional fees: Costs of drafting and negotiating licence agreements, enforcing the patent, and defending against infringement claims.
• Amortisation of patent costs: If the patent was purchased, the cost can be amortised over its remaining legal life (typically 20 years from filing date under the Patents Ordinance). The IRD accepts a straight-line method. For internally developed patents, the R&D costs are expensed, and no amortisation is permitted on the capitalised value of the patent itself.

A critical point: under the new section 16EB of the IRO, introduced by the 2024 amendment, a deduction for royalty payments made to a connected person in a low-tax jurisdiction is denied unless the Hong Kong payer can demonstrate that the recipient has sufficient economic substance in that jurisdiction. This is a direct anti-avoidance measure targeting back-to-back licensing structures.

Withholding Tax on Cross-Border Royalty Payments

Hong Kong does not impose a general withholding tax on royalties paid to non-residents. However, the position is different for royalties paid to a non-resident for the use of, or the right to use, a patent, trademark, or copyright in Hong Kong. Under section 15(1)(a) of the IRO, such payments are deemed to be profits arising in Hong Kong and are subject to profits tax at the standard rate, collected via withholding. The payer is required to deduct tax at the rate of 4.95% (for corporations) or 15% (for individuals) from the gross royalty payment and remit it to the IRD within 30 days.

The 4.95% Withholding Rate and the “Use in Hong Kong” Test

The 4.95% rate applies only when the non-resident recipient does not carry on business in Hong Kong through a permanent establishment (PE). If the non-resient has a PE in Hong Kong, the royalty income is assessable on a net basis under section 14, and the withholding mechanism does not apply. The “use in Hong Kong” test is fact-specific. A royalty paid by a Hong Kong manufacturer to a Swiss patent holder for the right to manufacture a patented component in its Hong Kong factory clearly falls within section 15(1)(a). Conversely, a royalty paid by a Hong Kong distributor to a US software company for the right to sub-license the software to customers in Japan is not for use in Hong Kong, and no withholding is required.

Treaty Relief: The US-HK and Mainland-HK Agreements

Hong Kong’s comprehensive double taxation agreements (DTAs) can reduce or eliminate the withholding tax on royalties.

• US-HK Tax Information Exchange Agreement (TIEA): The US-HK TIEA, which entered into force in 2014, does not provide for a reduced withholding rate on royalties. It is an information exchange agreement only, not a comprehensive DTA. Therefore, a US patent holder receiving royalties from a Hong Kong licensee for use in Hong Kong is subject to the full 4.95% withholding rate under Hong Kong domestic law.
• Mainland-China-HK DTA (Arrangement): Under Article 12 of the Arrangement between the Mainland of China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to Taxes on Income (2006, as amended), the withholding tax rate on royalties paid by a Hong Kong resident to a Mainland resident is capped at 7% of the gross amount. This is a reduction from the standard 10% rate under Mainland domestic law. The reduced rate applies only if the Hong Kong resident is the beneficial owner of the royalty and does not have a PE in the Mainland. For a Hong Kong company licensing a patent to a Mainland subsidiary, the 7% rate is a significant optimisation opportunity, provided the Hong Kong company has the economic substance to be the beneficial owner.

Practical Compliance and Record-Keeping for the Hong Kong IP Owner

The IRD’s increased focus on royalty income means that compliance is no longer a passive exercise. The taxpayer must maintain a robust audit trail for each royalty stream.

Documentation Required for an IRD Audit

In the event of an IRD investigation, the taxpayer should be prepared to produce:

1. The licence agreement: A fully executed, dated agreement that clearly states the IP being licensed, the territory, the royalty rate, the payment terms, and the duration.
2. Evidence of economic ownership: For patents held by a Hong Kong company, this includes board minutes authorising the R&D budget, records of strategic decisions on patent filing and enforcement, and employment contracts of local R&D staff. For a patent developed by a related party, the taxpayer must demonstrate that the Hong Kong entity paid arm’s-length consideration for the IP and that it exercises SPFs.
3. Proof of source: Evidence that the essential operations (negotiation, execution, enforcement) occurred outside Hong Kong, if the taxpayer claims the royalty is not sourced in Hong Kong. This could include correspondence with the licensee, records of meetings held outside Hong Kong, and the location of the bank account where the royalty is received.
4. Transfer pricing documentation: For transactions with connected persons, a transfer pricing study prepared in accordance with the IRD’s DIPN No. 46 (Revised 2023) on Transfer Pricing. The study must demonstrate that the royalty rate is arm’s-length, using comparable uncontrolled price (CUP) or transactional net margin method (TNMM).

Statute of Limitations and Voluntary Disclosure

The IRD can raise an assessment within six years after the end of the year of assessment in which the income accrued (section 60 of the IRO). For cases involving fraud or wilful evasion, the period extends to ten years. A taxpayer who discovers an error in a past return—such as failing to declare a royalty receipt—should consider making a voluntary disclosure under the IRD’s Voluntary Disclosure Programme. A timely, complete, and voluntary disclosure can result in a reduction of penalties, which would otherwise be up to 100% of the tax undercharged under section 82A.

Actionable Takeaways

1. Re-characterise your IP holding structure before the next profits tax return: If you hold a patent through a Hong Kong entity without local R&D substance, transfer the economic ownership of the IP to a jurisdiction with a comprehensive DTA with Hong Kong (e.g., the Mainland) or restructure to bring the SPFs into Hong Kong, before the IRD issues a transfer pricing adjustment under the new section 15FA.
2. Negotiate a clear territorial scope in every new licence agreement: To avoid the 4.95% withholding tax, ensure the licence agreement explicitly states that the IP is not to be used in Hong Kong, and that the payer’s business operations and the IP’s exploitation occur outside the territory.
3. Maintain a dedicated IP ledger for each patent: Record all R&D expenditure, registration costs, legal fees, and royalty receipts in a single, auditable ledger. This will substantiate both the “trade” test and the deductibility of expenses under section 16(1).
4. Review all related-party royalty payments for economic substance: For any royalty paid to a connected person in a low-tax jurisdiction, prepare a transfer pricing study that demonstrates the recipient’s SPFs, or risk having the deduction denied under section 16EB.
5. File a voluntary disclosure for any unreported royalty income from prior years: Given the six-year statute of limitations, a voluntary disclosure now can cap penalties and avoid a full IRD investigation, which would otherwise cover all open years.

---

Disclaimer / 免責聲明

本文不構成稅務建議。涉及個人稅務情況請諮詢持牌會計師或稅務師。

This does not constitute tax advice. Consult a licensed CPA or tax advisor for your specific situation.